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Resistant hypertension is a blood pressure that remains 
above the treatment goal despite use of optimal doses of 
three antihypertensive drugs of different classes including a 
diuretic (1). Patients with resistant hypertension should be 
screened for causes of secondary hypertension (2). Common 
causes of secondary hypertension include renal parenchymal 
disease (1), renovascular disease (3), dug-induced causes (4), 
pregnancy (5), primary aldosteronism (6), and obstructive 
s leep apnea (7) .  Uncommon causes  of  secondary 
hypertension include acromegaly, hyperthyroidism, 
hypothyroidism, hyperparathyroidism, Cushing syndrome, 
apparent mineralocorticoid excess, pheochromocytoma/
paraganglioma, carcinoid syndrome, congenital adrenal 
hyperplasia, coarctation of the aorta, and neurological 
causes (2). This article will discuss some of the drug-
induced causes of secondary hypertension.
Excessive dietary sodium intake contributes to resistant 
hypertension by directly increasing blood pressure and by 
blunting the efficacy of most classes of antihypertensive 
drugs (8). This effect is especially pronounced in salt-
sensitive persons such as older persons, blacks, and those 
with chronic kidney disease (1). Sodium-containing antacids 
should be avoided. Excessive alcohol use raises blood 
pressure and can cause resistance to antihypertensive drug 
therapy (4,9). Alcohol use should be restricted to ≤2 drinks 
daily for men and ≤1 drink daily for women (9). There is 
no difference in risk between beer, wine, and liquor (9). A 
meta-analysis of five studies in persons with hypertension 
showed that ingestion of 200 to 300 mg of caffeine caused 
an increase in blood pressure of 8.1/5.7 mm Hg, and the 
increase in blood pressure lasted for ≥3 hours (10). Persons 
with uncontrolled hypertension should avoid caffeinated 
beverages. Nicotine, cocaine, methamphetamine, and other 
recreational drugs which increase blood pressure should 
be avoided (2,9). Cocaine causes a severe increase in blood 
pressure, especially if the person is taking a beta blocker (4). 
Smoking cessation decreases systolic blood pressure (9).
Because of their widespread use, nonsteroidal anti-
inflammatory drugs, aspirin, and acetaminophen are 
the commonest drugs in worsening control of blood 
pressure (1).  Blood pressure is  increased by both 
cyclooxygenase 1-inhibitors and by cyclooxygenase 
2-inhibitors. Nonsteroidal anti-inflammatory drugs 
increase blood pressure by influencing prostaglandin 
production causing adverse renal effects (9). Nonsteroidal 
anti-inflammatory drugs also increase systemic vascular 
resistance by increased endothelin-1 synthesis and by 
altered arachidonic metabolism (9). In 9,411 patients aged 
65 years and older, use of nonsteroidal anti-inflammatory 
drugs increased the risk of starting antihypertensive 
drug treatment 1.55 times if low daily doses were 
used, 1.64 times if medium daily doses were used, and 
1.82 times if high daily doses were used (11). Nonsteroidal 
anti-inflammatory drugs also blunt the blood-pressure 
lowering of antihypertensive drugs including diuretics, 
angiotensin-converting enzyme inhibitors, angiotensin 
receptor blockers, and beta-adrenergic blockers (12,13). 
Nonsteroidal anti-inflammatory drugs should be avoided if 
possible in persons with hypertension and other analgesics 
used depending on the indication.
Amphetamine, methylphenidate dexmethylphenidate, 
and dextroamphetamine used to treat attention-deficit/
hyperactivity disorder in children and adolescents may 
cause an elevated blood pressure (14). Behavioral therapies 
should be considered for the treatment of this disorder. 
Antidepressants such as monoamine oxidase inhibitors, 
serotonin-norepinephrine reuptake inhibitors, and tricyclic 
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Persons taking monoamine oxidase inhibitors must avoid 
foods and beverages containing high levels of tyramine such 
as liver, alcohol beverages, and aged cheeses or they may 
have a hypertensive crisis. Atypical antipsychotics such as 
clozapine and olanzapine may also cause an elevated blood 
pressure (15). Their use should be limited when possible. 
Sympathomimetics such as the decongestants containing 
phenylephrine or pseudoephedrine may cause an elevated 
blood pressure (2). Alternative therapies such as nasal saline, 
intranasal corticosteroids, and antihistamines should be 
considered. Appetite suppressants may cause an elevated 
blood pressure (2). Herbal supplements such as ephedra, St 
John's wort, and yohimbine should be avoided since they 
have no clinical efficacy and may cause an elevated blood 
pressure (2). 
Systemic corticosteroids such as dexamethasone, 
fludrocortisone, methylprednisolone, prednisone, and 
prednisolone may cause an elevated blood pressure (4). The 
increase in blood pressure is dose dependent. Alternative 
ways of administration of these drugs such as inhalation 
or topical use should be considered. Mineralocorticoids 
including licorice, carbenoxolone, 9-alpha fluorocortisol, 
ketoconazole, and carbenoxolone may cause an elevated 
blood pressure (4,16). The increase in blood pressure 
caused by these drugs is dose-dependent and is associated 
with hypokalemia, metabolic alkalosis, and a reduction in 
plasma renin activity and aldosterone levels (4,9). 
Estrogens, androgens, and oral contraceptives may cause 
an increase in blood pressure (2,4,9). Oral contraceptives 
should not  be used in women with uncontrol led 
hypertension (4). Low-dose ethinyl estradiol (20–30 mcg) 
agents should be used (4). Alternative methods of birth 
control should be used. 
Immunosuppressants may cause an increase in blood 
pressure (2,4,9,17,18). Meta-analyses of randomized trials 
have demonstrated that cyclosporine treatment is associated 
with a higher incidence of hypertension than is treatment 
with tacrolimus (17,18).
Chronic use of recombinant human erythropoietin 
may cause hypertension (19). Mechanisms for the 
erythropoietin-induced hypertension include increase in 
hematocrit and erythrocyte mass, increased sensitivity to 
endogenous vasopressors, dysregulation of production 
or responsiveness to endogenous vasodilatory factors, a 
direct vasopressor effect, and stimulation of vascular cell 
growth (19). A sympathomimetic hypertensive crisis 
may be induced by abruptly stopping clonidine or other 
sympatholytic drugs or by using cocaine, amphetamines, 
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